InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,190.59
(
0.19%
)
US TECH 100
17,616.00
(
0.03%
)
Dow Jones
38,910.90
(
0.15%
)
Brent Oil
82.90
(
-0.69%
)
Bitcoin
63,553.24
(
0.61%
)
Post# of 251732
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 828
Posts 119581
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 212835

Friday, 08/18/2017 11:02:12 AM

Friday, August 18, 2017 11:02:12 AM

Post# of 251732
ABBV/ENTA’s Maviret* approved in Canada:

https://finance.yahoo.com/news/abbvies-maviret-approved-health-canada-130300201.html

ENTA does not receive a milestone payment from ABBV for Maviret approval in Canada, but ENTA does get a $15M milestone payment from ABBV for approval in Japan, which is expected in the next two quarters.

*Note spelling, which is the same as the brand name in the EU but differs from the “Mavyret” brand name in the US.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up